Article metrics

Original research
Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

 

Online download statistics by month:

Online download statistics by month: January 2024 to September 2024

AbstractFullPdf
Jan 2024466471210
Feb 202416616786
Mar 202410911396
Apr 2024929373
May 2024717358
Jun 2024868947
Jul 2024697140
Aug 20247877118
Sep 2024646538
Total12011219766